ACTION:
Notice of registration.
SUMMARY:
The registrant listed below has applied for and been granted registration by-the Drug Enforcement Administration (DEA) as an importer of schedule I controlled substances.
SUPPLEMENTARY INFORMATION:
The company listed below applied to be registered as an importer of scheduled I controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice.
| Company | FR Docket | Published |
|---|---|---|
| Agilent Technologies | 83 FR 66751 | December 27, 2018. |
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I controlled substances to the above listed company.
Dated: February 22, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-04026 Filed 3-5-19; 8:45 am]
BILLING CODE 4410-09-P